Peter C. Canning
15Patents
3h-index
28Co-inventors
60Inventor score
Filing activity: Oct 23, 1985 → Jan 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811130A | Injectable quinolone formulations | Human Necessities | 22 | Expired |
| US8278418B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 21 | Active |
| US8569233B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 17 | Active |
| US9644014B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 2 | Active |
| US4701323A | Vaccines for counteracting inhibition of neutrophil degranulation | Human Necessities | 2 | Expired |
| US9156899B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 2 | Active |
| US6979442B1 | Stabilized protein compositions | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10138283B2 | Modified bovine G-CSF polypeptides and their uses | Human Necessities | 1 | Active |
| US6608033B1 | Treatment or prevention of coccidiosis | Human Necessities | 1 | Expired |
| US11578111B2 | Porcine G-CSF variants and their uses | Human Necessities | 0 | Active |
| US10105447B2 | Method of treating obesity in a companion animal comprising administering a modified canine leptin polypeptide | Chemistry; Metallurgy | 0 | Active |
| US10960080B2 | Pegylated porcine interferon and methods of use thereof | Human Necessities | 0 | Active |
| US12286462B2 | Porcine G-CSF variants and their uses | Human Necessities | 0 | Active |
| US11542310B2 | Modified bovine G-CSF polypeptides and their uses | Human Necessities | 0 | Active |
| US10494760B2 | Methods and formulations for controlling human lice infestations | Textiles; Paper | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.